Peritonitis in PD Patients
Peritonitis in PD Patients
Peritonitis in PD Patients
dialysis patients
Dr Cherelle Fitzclarence
Renal GP
July 2009
Overview
Peritoneal Dialysis - principles
Anatomy
Physiology
Pathology
Presentations
Management
Key points
www.health.com/
Proteinuria
Care plan
STAGE 1 & 2
Proteinuria plus
eGFR 60+
(to determine eGFR
over 60, hand
calculate GFR using
Cockcroft-Gault
formula)
CKD
Care plan
STAGE 3
eGFR 3059
ml/min
ESKD
Care plan
STAGE 4
eGFR 15-29
ml/min
MODERATE
SEVERE
KIDNEY
KIDNEY
DAMAGE
DAMAGE
STAGE 5
PALLIATIVE CARE
eGFR <15
ml/min
FAILURE
DIALYSIS
HAEMODIALYSIS
PERITONEAL DIALYSIS
TRANSPLANTATION
Chronic
Kidney
Disease
Diagnosis
End Stage
Kidney
Disease
Diagnosis
Kidney
Failure
Peritoneal Dialysis
A form of renal replacement therapy for
dehydration
Set by:
Home Training Staff Royal Perth Hospital
Renal Doctor
Dialysis Staff KSDC
FLUID ASSESSMENT
Blood pressure
Weight
Chest, SaO2, SOB
Oedema
Ankles
Back
Facial
JVP
Skin tugor
Symptoms
Nausea,
vomiting
Diarrhoea
Dizziness
FLUID RESTRICTION
800 1000 mls per day
Weigh patient (will be required daily
Peritoneal Dialysis
Involves the passage of solutes and water
http://www.dialyse-45.net/int/info/techniques.htm
Peritoneal Dialysis
2 types
Peritoneal Dialysis
Anatomy
Serosal membrane lining the gut
Thought to be the same as the body surface
area usually 1-2 m2 in adult
2 parts visceral peritoneum lining the organs
(80% or the peritoneal surface area and the
parietal peritoneum lining the walls of the
abdominal cavity)
Peritoneal blood flow cant be measured but
indirectly estimated to be between 50100mls/min
Peritoneal Dialysis
Peritoneal Dialysis
Visceral peritoneum blood supply is from the
peritoneal transport
Movement of solute and water movement
across the capillary is mediated by pores of
three different sizes
Large pores 20-40 nm protein transport
Small pores 4-6nm small solutes eg urea,
creatinine, sodium, potassium, water
Ultrapores (aquaporins) <0.8nm transport of
water
Kidney International
ISSN: 0085-2538
EISSN: 1523-1755
2009 International Society of Nephrology
Diffusion
www.indiana.edu/.../lecture/lecnotes/diff.html
Ultrafiltration
http://www.dialysistips.com/principles.html
Ultrafiltration
http://www.advancedrenaleducation.com/PeritonealDialysis/Ultrafiltration/HowtoAchieveAdequatePDUF/tabid/229/Default.aspx
http://www.fmc-ag.com/gb_2006/en/05/glossar.html
Peritonitis
Peritoneal Dialysis is a great form of renal
replacement therapy
Peritonitis is a significant complication
Incidence peritonitis episodes varies from 1/9
patient-months to 1/53 patient-months (
Grunberg 2005; Kawaguchi 1999)
Our figures pending but are likely to be on
the lower end of the scale
Peritonitis in PD pts
Risk Factors
Diabetes
Non caucasian
Obesity
Temperate climate
Depression
Possibly the peritoneal dialysis
modality but not proven
Huang 2001; Oo 2005).
(
http://www.diabetesandrelatedhealthissues.
com/
Peritonitis in PD pts
Significant morbidity
Some mortality - It is estimated that PD-
gymsoap.com
Peritonitis in PD pts
Catheter removal may become necessary if
Pathogenesis
1. Potential routes of infection
Intraluminal improper technique; access to
bacteria via the catheter lumen
Periluminal bacteria present on skin surface
enter the peritoneal cavity via the catheter
tract
Transmural bacteria of intestinal origin
migrate through the bowel wall
Haematogenous peritoneum seeded via the
blood stream
Transvaginal - ??
Pathogenesis
2. Bacteria laden plaque the intraperitoneal portion
Aetiology
Staph aureus
Coag neg staph (S.Epidermidis)
E coli
Pseudomonas
Sternotropomonas
Candida
Atypical TB
Diagnosis
2 of the following 3 conditions
95
30
Fever
30
Chills
20
Constipation or diarrhoea
15
Signs
Cloudy peritoneal fluid
99
Abdo tenderness
80
Rebound tenderness
10-50
Increased temperature
33
Blood leucocytosis
25
CRP
Peritonitis
Common things occur commonly and
Peritonitis Management
Broad spectrum coverage
Vancomycin (2.5g if more than 60kg / 2 g if 60kg or
less)
Gentamicin (200mg if more than 60kg / 140mg if 60kg
or less)
IP is better than IV (confirmed on large Cochrane
PERITONITIS MANAGEMENT
Initial symptoms may include;
diarrhoea, vomiting, nausea,
abdominal pain, mental confusion or feeling unwell
COLLECT DRAINED BAG
*See additional resources (pink section) for drainage instructions
* Send entire bag for urgent MC&S (including WCC differential) and Fungal elements. ****
Must cc KRSS ****
CLEAR BAG
must be able to read newspaper
the bag
CLOUDY BAG
Give BOTH
Gentamycin
160mgs if 60kgs or less
(gram ve organisms)
200mg if > 60kgs
AND
Vancomycin 2gms if 60kgs or less
(gram +ve organisms)
2.5grams if > 60kgs
Give both in a 2L 2.3% bag
Peritonitis Mx
CAPD/APD
Peritonitis
If you think that the patient has peritonitis but you
Peritonitis
Patients can have dual pathology
Eg it is not uncommon for patients to have
Peritonitis
Additives to bags
Vancomycin, aminoglycosides and
cephalosporins are safe to mix in the same
bag
Aminoglycosides are incompatible with
penicillins
Vancomycin is stable for 28 days in dialysate
(normal room temp)
Cefazolin is stable for 8 days
Gentamicin is stable for 14 days
Heparin added decreases duration of stability
Peritonitis
Often get formation of fibrin clots which
Peritonitis
Fluid regimes
Depends whether patient is overloaded or
underloaded
Can usually continue normal regime but tailor to
patient
If BP low, use 1.5% bags x 4 a day
If BP high use 2.3% bags, minimum of 4 a day
Aim for BP 120/
APD pts can continue on APD or if needed can
convert temporarily to CAPD in Broome with
resources this should not be necessary
Peritonitis
Can get changes in the permeability of the peritoneal
membrane
Peritonitis
Dont forget secondary causes of peritonitis
Peritonitis
You dont necessarily have to admit the
patient
Admission dictated by symptoms and
distress and often social circumstances up
here
cms.ich.ucl.ac.uk/website/imagebank/images
blogs.southshorenow.ca/louise/
Peritonitis - bugs
Staph Vancomycin and repeat in 1 week
Patients should have nasal carriage treated with
mupirocin bd for 5 days and then once a week of bd
for 5 days once a month
Gram Negs IP Ceftriaxone for 2 weeks and
Peritonitis
Multiple organisms
Have a high index of suspicion for secondary
peritonitis
If not secondary peritonitis have 60% chance of curing
with appropriate antibiotics
If one of the organisms is clostridium or bacteroides
likely intra-abdominal abscess or perforated abdominal
viscus but exclude appendicitis, perforated ulcer,
pancreatitis and any other cause of secondary
peritonitis
Occurrence of abdominal catastrophe in PD patient
has a high mortality
Talk to the surgeon
Add metronidazole
Ship south
Peritonitis
Culture negative disease
If cell count less than 50 x 106unlikely to
peritonitis
If higher white cell count, then repeat empiric
therapy
Make sure lab is doing cultures for AFBs and
fungus
If not improving consider legionella,
campylobacter, ureaplama, mycoplasma,
enteroviruses, fungus, histoplasma
capsulatum
Peritonitis
Fungal peritonitis
Predisposing factors
Peritonitis
Fungal peritonitis
Peritonitis
Refractory disease
Defined as disease that is treated with
Peritonitis
Relapsing disease
Peritonitis with the same organism within 4 weeks of stopping
therapy
Usually Staph epidermidis or a gram negative organism
If pseudomonas or gram negatives, remove the catheter
If staph, may be able to rescue with repeat vancomycin weekly
for a month or may be able to remove the tube and
simultaneously insert a new tube (as opposed to any other
organism where a 2 month peritoneal rest is required)
Sometimes can use urokinase to strip the biofilm (bacteria
entrapped in fibrin in the peritoneal membrane) in relapsing
disease last resort but worth a go
Peritonitis
20% of episodes temporally associated with
Peritonitis
Prevention
Good technique
Hygiene
Mupirocin
Exit site care
Anchor tape
Specific interventions that would be of value include early versus late catheter removal.
Studies designed to study infections due to specific organisms would also be valuable. An
example is a study of glycopeptide versus cephalosporin therapy in peritonitis due to
coagulase negative Staphylococcal species. The majority of studies have included patients
on CAPD rather than APD hence studies designed to test the efficacy of antibiotics in APD
are required. This is particularly applicable to studies of intermittent versus continuous
dosing when cycler dwell times may well influence pharmacokinetics.
www.learningradiology.com
Acknowledgements
Thanks to Daugirdas et al 2007 Handbook
of dialysis
http://mrw.interscience.wiley.com/cochrane/cl
sysrev/articles/CD005284/frame.html
Thank you
Questions
renalgp@kamsc.org.au